Ruth Paris1, Anna L Herriott2, Mihoko Maru3, Sarah E Hacking4, Amy R Sommer5. 1. Boston University School of Social Work, 264 Bay State Road, Boston, MA, 02215, USA. rparis@bu.edu. 2. School of Social Service Administration, University of Chicago, Chapin Hall, Hyde Park Campus, Chicago, IL, 60637, USA. 3. Boston University School of Social Work, 264 Bay State Road, Boston, MA, 02215, USA. 4. The Home for Little Wanderers, Preschool Outreach Program, 780 American Legion Highway, Roslindale, MA, 02131, USA. 5. Jewish Family & Children's Service, 1430 Main St., Waltham, MA, 02451, USA.
Abstract
OBJECTIVES: Substance misuse during pregnancy can be harmful to the health of both mothers and infants. Existing recovery services or prenatal care for pregnant women with substance use disorders (SUD) in the U.S. and other countries typically fall short in providing the necessary specialized care women with SUDs need. Disclosure of substance misuse is one key factor in gaining access to specialized prenatal care; yet, barriers such as social stigma and internal shame and guilt lead many women to under-report any substance misuse during their pregnancy. This study sought to understand the process of how and why pregnant women with SUDs choose to disclose or not disclose their substance misuse to their providers when seeking prenatal care. METHODS: Data were collected through interviews with N = 21 women with SUDs in the northeast U.S. whose young children had been exposed to opioids, cocaine, or MAT in utero. Thematic, inductive analysis using line-by-line coding was conducted to understand the perspectives of the women. RESULTS: The women's narratives suggested a clear tension regarding whether to disclose their substance misuse to any providers during their pregnancy. Four themes describing the process of disclosure or non-disclosure were found, including reasons for and ways of being secret or choosing to disclose their substance misuse during pregnancy. CONCLUSIONS FOR PRACTICE: The centrality of shame, guilt, and stigma regarding substance misuse must be addressed by medical and mental health providers in order to increase disclosure and improve access to care for women with SUDs.
OBJECTIVES: Substance misuse during pregnancy can be harmful to the health of both mothers and infants. Existing recovery services or prenatal care for pregnant women with substance use disorders (SUD) in the U.S. and other countries typically fall short in providing the necessary specialized care women with SUDs need. Disclosure of substance misuse is one key factor in gaining access to specialized prenatal care; yet, barriers such as social stigma and internal shame and guilt lead many women to under-report any substance misuse during their pregnancy. This study sought to understand the process of how and why pregnant women with SUDs choose to disclose or not disclose their substance misuse to their providers when seeking prenatal care. METHODS: Data were collected through interviews with N = 21 women with SUDs in the northeast U.S. whose young children had been exposed to opioids, cocaine, or MAT in utero. Thematic, inductive analysis using line-by-line coding was conducted to understand the perspectives of the women. RESULTS: The women's narratives suggested a clear tension regarding whether to disclose their substance misuse to any providers during their pregnancy. Four themes describing the process of disclosure or non-disclosure were found, including reasons for and ways of being secret or choosing to disclose their substance misuse during pregnancy. CONCLUSIONS FOR PRACTICE: The centrality of shame, guilt, and stigma regarding substance misuse must be addressed by medical and mental health providers in order to increase disclosure and improve access to care for women with SUDs.
Authors: Hendrée E Jones; Hannah B Apsley; Anya Cocowitch; Tina Merrill; Sarah McGlothlin; Rachel Middlesteadt-Ellerson; Kim Andringa; Kevin E O'Grady Journal: Drug Alcohol Depend Date: 2021-12-30 Impact factor: 4.492
Authors: Ximena A Levander; Canyon A Foot; Sara L Magnusson; Ryan R Cook; Jerel M Ezell; Judith Feinberg; Vivian F Go; Kathryn E Lancaster; Elizabeth Salisbury-Afshar; Gordon S Smith; Ryan P Westergaard; April M Young; Judith I Tsui; P Todd Korthuis Journal: J Gen Intern Med Date: 2022-06-15 Impact factor: 6.473
Authors: Davida M Schiff; Erin C Work; Serra Muftu; Shayla Partridge; Kathryn Dee L MacMillan; Jessica R Gray; Bettina B Hoeppner; John F Kelly; Shelly F Greenfield; Hendrée E Jones; Timothy E Wilens; Mishka Terplan; Judith Bernstein Journal: J Subst Abuse Treat Date: 2022-03-18
Authors: Natalie M Brousseau; Heather Farmer; Allison Karpyn; Jean-Philippe Laurenceau; John F Kelly; Elizabeth C Hill; Valerie A Earnshaw Journal: J Subst Abuse Treat Date: 2021-08-09
Authors: Karina Beltrán-Arzate; Kevin Hodson; Haley K Tes; Sarah-Anne H Bowyer; Hollis C Ratliff; Michael M Abraham; Elizabeth Johnson; Malinda Harris; Julia Jaekel Journal: Womens Health (Lond) Date: 2021 Jan-Dec
Authors: Rebecca R S Clark; Rachel French; Scott Lorch; Kathleen O'Rourke; Kathleen E Fitzpatrick Rosenbaum; Eileen T Lake Journal: Hosp Pediatr Date: 2021-07-06